Highly Potent and Conformal Alpha Emitters Radiotherapy for the Treatment of Solid Cancer Tumors

The Alpha DaRT Technology


The Alpha DaRT breakthrough technology utilizes Alpha radiation to treat cancer. DaRT (Diffusing Alpha-emitters Radiation Therapy) treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha-emitting atoms into the tumor.

Alpha DaRT Clinical Trials


Alpha Tau Medical is currently running clinical trials for:

- Skin Cancer
- Head and Neck Cancer

The company is working with leading cancer researchers to commence additional trials for further indications.

The Alpha DaRT Treatment

Alpha DaRT enables a highly potent and conformal radiation treatment for solid cancer tumors. Directly inserted into the tumor, the Alpha DaRT seeds release a high-energy dose over a range of several millimeters enabling a focal alpha-radiation treatment that spares the surrounding healthy tissue. The Alpha DaRT treatment has several significant clinical advantages…

About Alpha Tau Medical

Alpha Tau Medical is an Israeli MedTech company that focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.



  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon


Are you looking to participate in clinical trials?

Take our self-assessment test to find potentially suitable studies.

For other inquiries, please visit our contact page.